Related Experiment Video
Updated: Apr 4, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Does Haptoglobin Phenotype Influence Postnatal Morbidity in Preterm Neonates?
Irena Kessel1, Maayan Leib2, Andrew Levy2
1Department of Neonatology Carmel Medical Center, Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Background:
Haptoglobin (Hp) is an acute phase protein with antioxidant, bacteriostatic, and anti-inflammatory activities. Hp proteins associated with the three major phenotypes differ in their proinflammatory and anti-inflammatory action. Inflammation and oxidative stress are both involved in most pathophysiological processes in premature infants. The objective of this study was to determine whether Hp phenotype influences clinical manifestations and sepsis incidence in the premature infants.
Objective:
Infants born before 35 weeks gestational age were prospectively evaluated for Hp phenotype and clinical events, including sepsis, necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage, and retinopathy of prematurity. The participants were observed until discharge.
Methods:
A total of 122 preterm infants were enrolled in the study. Clinical events were not affected by the Hp phenotype. The expression of Hp protein was extremely low in the study population. More septic episodes were found in infants with a birth weight greater than 1,500 g, although, the difference was not statistically significant.
Results:
Extremely low expression of Hp may explain the lack of a correlation between Hp phenotype and sepsis in preterm infants. Further research involving a larger neonatal population is required to better understand the role of the Hp phenotype in morbidity of premature infants.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Rh Blood Group
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Multiple Allele Traits
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

